P

Inventor

HOFMANN HANS P

DE19 patents
⚠️ This page may combine multiple inventors who share the name “HOFMANN HANS P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BASF AG

17 patents
US4618622AOct 21, 1986

Sulfonates of hydroxycoumarins

BASF AG19 citations81
US5512584AApr 30, 1996

1,3,4-trisubstituted piperidine derivatives, the preparation and use thereof

BASF AG9 citations73
US5371088ADec 6, 1994

1-aryl-4-piperazinylcyclohexanecarbonitriles, the preparation and use thereof

BASF AG3 citations62
US5342839AAug 30, 1994

2-hydroxy-3-phenoxy-propyl-substituted piperazines, their preparation and use

BASF AG2 citations62
US5153228AOct 6, 1992

9-amino-2-phenylbicyclo[3.3.1]nonanes and 9-amino-2-phenylbicyclo[3.3.1]non-2-enes and drugs containing them

BASF AG5 citations62
US4619929AOct 28, 1986

Phenylpiperazine derivatives of hetarylphenols and hetarylanilines, their preparation, and therapeutic agents containing these compounds

BASF AG3 citations62
US4564641AJan 14, 1986

Substituted 1-oxo-2-phenyl-2-(2-alkylaminoethyl)-1,2,3,4-tetrahydronaphthalenes, their preparation and their use

BASF AG5 citations62
US4362727ADec 7, 1982

5-Substituted 9-cyanomethylene-dithieno[3,4-b:4,3-e]-azepines and therapeutic agents which contain these compounds

BASF AG5 citations62
US4183935AJan 15, 1980

Bispidine derivatives, their preparation, and drugs containing same

BASF AG5 citations62
US4499087AFeb 12, 1985

7-Phenyl-7-phenoxymethyl-hexahydro-1,4-oxazepines and their use

BASF AG5 citations61
US5538972AJul 23, 1996

Imidazoloquinoxalinones for the treatment of central nervous disorders

BASF AG0 citations52
US5049583ASep 17, 1991

Noremopamil, and its use for treating hypoxic conditions

BASF AG0 citations52
US4548933AOct 22, 1985

Sedative compositions containing 10-piperazino-5-cyanomethylene-dibenzo[a,d]-cycloheptenes

BASF AG1 citations52
US4447610AMay 8, 1984

10-Substituted 5-cyanomethylene-dibenzo[A,B]-cycloheptenes, their preparations, and therapeutic agents containing these compounds

BASF AG0 citations52
US5631261AMay 20, 1997

Triazoloquinazolines, their preparation and use

BASF AG0 citations51
US4376773AMar 15, 1983

10-Substituted 5-cyanomethylene-10,11-dihydro-dibenzo-[a,d]-cycloheptenes, their preparation, and therapeutic agents containing these compounds

BASF AG0 citations51
US5612344AMar 18, 1997

Triazoloquinazolines for the treatment of central nervous disorders

BASF AG0 citations41

TUV BAYERN E V

1 patent

TECH UEBERWACHUNGSVEREI BAYERN

1 patent